Evidence map›Paper›PMID 41948727›Full record

SynthesisFrontiers in pharmacology2026

Mechanisms of active metabolites from traditional Chinese medicine in osteoarthritis: a critical review.

Hui Li, Yongli Zhao, Peng Qi, Bo Zhang, Jilong Ma, Xingwen Xie, Ning Li

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Mechanisms of resveratrol in cartilage injury repair and protection: A review.The Journal of international medical research · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui Li *Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Yongli Zhao *Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Peng QiGansu University of Traditional Chinese Medicine, Lanzhou, China.
Bo ZhangAffiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Jilong MaAffiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Xingwen XieAffiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Ning LiAffiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a prevalent degenerative joint disease with multifactorial pathogenesis and no cure. Traditional Chinese Medicine (TCM) is widely used in OA management, and accumulating research suggests that bioactive metabolites (formerly termed active components) from TCM botanical drugs can modulate key pathological processes in OA. Traditional Chinese medicine has an important role in OA management owing to its relatively low incidence of adverse effects, affordability, and multi-target therapeutic actions. In this review, we systematically searched PubMed and Web of Science (2010-2025) for studies on TCM-derived metabolites in OA using keywords such as "osteoarthritis," "Traditional Chinese Medicine," "active constituent," and "mechanism." Relevant

Indexed as

active metabolitecartilageinflammationmechanismosteoarthritissignaling pathwaystraditional Chinese medicine

Identifiers

PMID41948727
PMCPMC13050936

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.